Fig. 6: Inhibition of HOXC6 contributes to enhanced chemotherapy sensitivity. | Cell Death & Disease

Fig. 6: Inhibition of HOXC6 contributes to enhanced chemotherapy sensitivity.

From: HomeoboxC6 promotes metastasis by orchestrating the DKK1/Wnt/β-catenin axis in right-sided colon cancer

Fig. 6

A HCT116 cells in the siHOXC6 group were more sensitive to 5-Fu, irinotecan, 5-Fu + irinitecan and 5-Fu + irinitecan+oxaliplatin compared to those in the siCtrl group. B HT29 cells in the siHOXC6 group were more sensitive to irinotecan, 5-Fu + irinitecan and 5-Fu + irinitecan+oxaliplatin compared to those in the siCtrl group. C Schematic diagram of HOXC6 promote metastasis via DKK1/Wnt/β-catenin axis in RCC. *: P < 0.05; **: P < 0.01; ***: P < 0.001.

Back to article page